• Careers
    • Open Positions
    • Postdoctoral Training
    • Internships
    • Immigration Services
  • Contact
    • Media Inquiries
  • Intranet
La Jolla Institute for Immunology
  • Research
    • Databases
      • Database of Immune Cell Epigenomics
      • Immune Epitope Database
    • Diseases (A-Z)
    • Licensing Opportunities
    • Initiatives
    • Publications
    • Research Centers
      • Center for Autoimmunity and Inflammation
      • Center for Cancer Immunotherapy
      • Center for Infectious Disease and Vaccine Research
    • Research Services
      • Bioinformatics
      • Clinical Studies
      • Cryo-EM
      • DLAC
      • Flow Cytometry
      • Histopathology
      • Microscopy & Histology
      • Next Generation Sequencing
    • Legal Affairs & IP
  • Labs
    • Ay Lab
    • Benedict Lab
    • Cheroutre Lab
    • Croft Lab
    • Crotty Lab
    • Grifoni Lab
    • Hedrick Lab
    • Hogan Lab
    • Kawakami Lab
    • Kronenberg Lab
    • Ley Lab
    • Lindestam Arlehamn Lab
    • Myers Lab
    • Peters Lab
    • Rao Lab
    • Saphire Lab
    • Schoenberger Lab
    • Sette Lab
    • Seumois Lab
    • Sharma Lab
    • Shresta Lab
    • Vijayanand Lab
    • von Herrath Lab
    • Weiskopf Lab
  • News
    • Blog
    • Life Without Disease STORIES
    • Magazine
    • News
    • Videos
  • Events
    • Art Competition
    • Life Without Disease Event Series
    • Live from the Lab
    • Scientific Seminars
  • About Us
    • Overview
      • History
      • Institute Facts
    • Our Team
      • Leadership
      • Faculty
        • Emeriti
        • Clinical Associates
      • Board of Directors
      • Scientific Advisory Board
    • Statements
      • LJI Diversity and Inclusion Statement
      • Vaccines
  • Support
    • Overview
    • Giving Opportunities
      • The Tullie and Rickey Families SPARK Program
      • Center for Precision Immunotherapy
      • Together for Asthma
      • SURGE Program
    • Ways to Give
    • Vanguard Giving Society
    • Planned Giving
    • CARES Act
    • Advancement Team
    • Clinical Studies
    • DONATE
  • Careers
    • Open Positions
    • Postdoctoral Training
    • Postdoctoral Association
    • Internships
  • Contact
    • Media Inquiries
Support

Publications

Reset
Mar 18, 2022 iScience
Combined assessment of MHC binding and antigen abundance improves T cell epitope predictions
Koşaloğlu-Yalçın Z, Lee J, Greenbaum J, Schoenberger SP, Miller A, Kim YJ, Sette A, Nielsen M, Peters B.
Mar 3, 2022 Proc Natl Acad Sci U S A
Developmentally distinct CD4 + T reg lineages shape the CD8 + T cell response to acute Listeria infection
Dolina JS, Lee J, Moore EL, Hope JL, Gracias DT, Matsutani T, Chawla A, Greenbaum JA, Linden J, Schoenberger SP.
Aug 24, 2021 Front Immunol.
The cancer epitope database and analysis resource: a blueprint for the establishment of a new bioinformatics resource for use by the cancer immunology community.
Koşaloğlu-Yalçın Z, Blazeska N, Carter H, Nielsen M, Cohen E, Kufe D, Conejo-Garcia J, Robbins P, Schoenberger SP, Peters B, Sette A.
Mar 30, 2021 Proc Natl Acad Sci U S A.
Single-cell analysis of immune repertoires enabled.
Schoenberger SP.
Mar 14, 2020 J Leukoc Biol
Harnessing Neoantigen Specific CD4 T Cells for Cancer Immunotherapy
Brightman SE, Naradikian MS, Miller AM, Schoenberger SP.
Oct 7, 2019 Cancer Immunol Res
Irreversible electroporation combined with checkpoint blockade and TLR7 stimulation induces antitumor immunity in a murine pancreatic cancer model
Narayanan JSS, Ray P, Hayashi T, Whisenant TC, Vicente D, Carson DA, Miller AM, Schoenberger SP, White RR
Mar 18, 2019 Front Immunol
A threshold model for T-cell activation in the era of checkpoint blockade immunotherapy
Guram K, Kim SS, Wu V, Sanders PD, Patel S, Schoenberger SP, Cohen EEW, Chen SY, Sharabi AB
Jan 1, 2019 Cancer Immunol Res
Leveraging TCR affinity in adoptive immunotherapy against shared tumor/self-antigens
Miller AM, Bahmanof M, Zehn D, Cohen EEW, Schoenberger SP
Nov 1, 2018 Cold Spring Harb Perspect Biol
Is it possible to develop cancer vaccines to neoantigens, what are the major challenges, and how can these be overcome? Targeting the right antigens in the right patients
Schoenberger SP
Oct 10, 2018 Front Immunol
Class-B CpG-ODN formulated with a nanostructure induces type I interferons-dependent and CD4+ T cell-independent CD8+ T-cell response against unconjugated protein antigen
Chiodetti AL, Sánchez Vallecillo MF, Dolina JS, Crespo MI, Marin C, Schoenberger SP, Allemandi DA, Palma SD, Pistoresi-Palencia MC, Morón G, Maletto BA
Jul 21, 2018 J Transl Med
Perspectives in melanoma: Meeting report from the melanoma bridge (30 November-2 December, 2017, Naples, Italy)
Ascierto PA, Puzanov I, Agarwala SS, Bifulco C, Botti G, Caracò C, Ciliberto G, Davies MA, Dummer R, Ferrone S, Gajewski TF, Garbe C, Luke JJ, Marincola FM, Masucci G, Mehnert JM, Mozzillo N, Palmieri G, Postow MA, Schoenberger SP, Wang E, Thurin M
Jul 21, 2018 J Transl Med
Perspectives in melanoma: Meeting report from the melanoma bridge (30 November–2 December, 2017, Naples, Italy)
Ascierto PA, Puzanov I, Agarwala SS, Bifulco C, Botti G, Caracò C, Ciliberto G, Davies MA, Dummer R, Ferrone S, Gajewski TF, Garbe C, Luke JJ, Marincola FM, Masucci G, Mehnert JM, Mozzillo N, Palmieri G, Postow MA, Schoenberger SP, Wang E, Thurin M
  • 1
  • 2
  • 3
  • 4
  • Contact Us
  • Careers
  • Terms & Conditions
  • Privacy Policy
La Jolla Institute for Immunology

contact@lji.org
9420 Athena Circle
La Jolla, CA 92037

Phone: +1 (858) 752-6500

© 2020 La Jolla Institute for Immunology. All rights reserved. LJI is a 501(c)(3) tax-exempt organization. Federal Tax ID Number 33-0328688






 

Location: